|
Volumn 95, Issue 1, 2010, Pages
|
Missed opportunities for preventing group B streptococcus infection
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN PLUS CLAVULANIC ACID;
ANTIBIOTIC AGENT;
CEPHALOSPORIN;
CLINDAMYCIN;
METRONIDAZOLE;
PENICILLIN G;
ARTICLE;
BACTERIUM CULTURE;
CHORIOAMNIONITIS;
CLINICAL ARTICLE;
CLINICAL ASSESSMENT;
CLINICAL FEATURE;
CLINICAL TRIAL;
DISEASE SURVEILLANCE;
FEMALE;
GESTATIONAL AGE;
GROUP B STREPTOCOCCAL INFECTION;
HUMAN;
INFANT;
INFORMATION PROCESSING;
INTRAPARTUM CARE;
LIVE BIRTH;
MALE;
MORTALITY;
MOTHER;
MULTICENTER STUDY;
NEWBORN;
NEWBORN INFECTION;
NEWBORN INTENSIVE CARE;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RETROSPECTIVE STUDY;
RISK FACTOR;
SEPSIS;
TREATMENT OUTCOME;
ANTI-BACTERIAL AGENTS;
ANTIBIOTIC PROPHYLAXIS;
FEMALE;
GREAT BRITAIN;
HUMANS;
INFANT, NEWBORN;
INFANT, PREMATURE;
INFECTIOUS DISEASE TRANSMISSION, VERTICAL;
MALE;
PRACTICE GUIDELINES AS TOPIC;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
PREMATURE BIRTH;
PROSPECTIVE STUDIES;
RISK FACTORS;
SEPSIS;
STREPTOCOCCAL INFECTIONS;
STREPTOCOCCUS AGALACTIAE;
TREATMENT OUTCOME;
|
EID: 74749089485
PISSN: 13592998
EISSN: 14682052
Source Type: Journal
DOI: 10.1136/adc.2009.160333 Document Type: Article |
Times cited : (52)
|
References (5)
|